Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-11-16 Purchase | 2023-11-17 4:55 pm | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 90,000 | $1.0533 | $94,797 | 914,359 (Direct) | View |
| 2023-11-10 Purchase | 2023-11-13 5:31 pm | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 10,000 | $1.01 | $10,100 | 824,359 (Direct) | View |
| 2023-06-29 Purchase | 2023-06-29 4:13 pm | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 10,000 | $2.16 | $21,600 | 814,359 (Direct) | View |
| 2023-06-23 Purchase | 2023-06-26 4:04 pm | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 20,000 | $2.3371 | $46,742 | 804,359 (Direct) | View |
| 2023-06-22 Purchase | 2023-06-22 4:01 pm | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 40,000 | $2.31 | $92,400 | 784,359 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-26 Option Award | 2024-06-28 07:45 am | N/A 2034-06-25 | Verve Therapeutics Inc. | VERV | COATS LONNEL Director | 136,139 | $0 | 136,139 (Direct) | View |
| 2024-06-12 Option Award | 2024-06-14 5:37 pm | N/A 2034-06-12 | Blueprint Medicines Corp | BPMC | COATS LONNEL Director | 6,812 | $0 | 17,824 (Direct) | View |
| 2024-02-28 Tax Withholding | 2024-02-29 4:26 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 61,371 | $2.62 | 1,430,198 (Direct) | View |
| 2024-02-28 Exercise | 2024-02-29 4:26 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 245,080 | $0 | 1,430,198 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 4:12 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 1,540,840 | $0 | 1,540,840 (Direct) | View |
| 2023-06-21 Option Award | 2023-06-23 7:04 pm | N/A 2032-06-21 | Blueprint Medicines Corp | BPMC | COATS LONNEL Director | 7,900 | $0 | 16,312 (Direct) | View |
| 2023-06-15 Option Award | 2023-06-20 5:00 pm | N/A 2033-06-14 | Verve Therapeutics Inc. | VERV | COATS LONNEL Director | 26,642 | $0 | 26,642 (Direct) | View |
| 2023-02-28 Tax Withholding | 2023-03-01 4:46 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 50,971 | $2.17 | 960,419 (Direct) | View |
| 2023-02-28 Exercise | 2023-03-01 4:46 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 209,327 | $0 | 960,419 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-13 4:55 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 1,444,590 | $0 | 1,444,590 (Direct) | View |
| 2022-08-08 Option Award | 2022-08-09 5:05 pm | N/A 2032-08-07 | Verve Therapeutics Inc. | VERV | COATS LONNEL Director | 31,000 | $0 | 31,000 (Direct) | View |
| 2022-06-21 Option Award | 2022-06-30 9:57 pm | N/A 2032-06-21 | Blueprint Medicines Corp | BPMC | COATS LONNEL Director | 7,900 | $0 | 13,712 (Direct) | View |
| 2022-02-28 Exercise | 2022-02-28 7:11 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 197,343 | $0 | 737,300 (Direct) | View |
| 2022-02-28 Tax Withholding | 2022-02-28 7:11 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 48,053 | $2.85 | 737,300 (Direct) | View |
| 2022-02-10 Option Award | 2022-02-14 4:05 pm | N/A 2032-02-10 | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL Chief Executive Officer | 1,096,370 | $0 | 1,096,370 (Direct) | View |
| 2021-06-02 Option Award | 2021-06-04 4:19 pm | N/A 2031-06-02 | Blueprint Medicines Corp | BPMC | COATS LONNEL Director | 6,750 | $0 | 10,312 (Direct) | View |
| 2021-02-28 Tax Withholding | 2021-03-02 4:57 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL President and CEO | 55,038 | $7.19 | 685,353 (Direct) | View |
| 2021-02-28 Exercise | 2021-03-02 4:57 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL President and CEO | 192,885 | $0 | 685,353 (Direct) | View |
| 2021-02-11 Option Award | 2021-02-16 4:10 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL President and CEO | 400,000 | $0 | 400,000 (Direct) | View |
| 2020-06-24 Option Award | 2020-06-26 4:11 pm | N/A 2030-06-24 | Blueprint Medicines Corp | BPMC | COATS LONNEL Director | 6,750 | $0 | 8,062 (Direct) | View |
| 2020-06-19 Exercise | 2020-06-23 4:19 pm | N/A N/A | Blueprint Medicines Corp | BPMC | COATS LONNEL Director | 1,312 | $0 | 1,312 (Direct) | View |
| 2020-02-28 Exercise | 2020-03-03 4:11 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL President and CEO | 116,647 | $0 | 486,501 (Direct) | View |
| 2020-02-28 Tax Withholding | 2020-03-03 4:11 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL President and CEO | 45,320 | $2.77 | 486,501 (Direct) | View |
| 2020-02-06 Option Award | 2020-02-10 4:06 pm | N/A N/A | LEXICON PHARMACEUTICALS INC. | LXRX | COATS LONNEL President and CEO | 1,015,550 | $0 | 1,015,550 (Direct) | View |